Ikonisys S.A.
ALIKO | XPAR
Overview
Corporate Details
- ISIN(s):
- FR00140048X2
- LEI:
- 9695000B742KPNDQ4D05
- Country:
- France
- Address:
- 62 RUE DE CAUMARTIN, 75009 PARIS
- Website:
- https://www.ikonisys.com
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Ikonisys is transforming diagnostic medicine by enabling early, accurate and non-invasive disease detection. Through a unique combination of technology and science, Ikonisys is dedicated to helping physicians and researchers realize the promise of rare cell detection to give patients the best chance of managing their disease. Through its breakthrough fluorescence microscopy platform, Ikonisys continues to develop a stream of oncology tests for a variety of cancers. At the center of the platform is the Ikoniscope20®, a robotic, high-throughput, microscopy system that provides a true “walk away” automated solution. In addition to providing high quality cell images, the platform analyzes the cells of interest, offering an interpretation of the analysis, to facilitate the quick, accurate reporting of the test result.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-02 17:45 |
Inside Information Statement
Informations privilégiées / Autres communiqués
|
French | 343.4 KB | |
| 2025-05-02 17:45 |
Capital/Financing Update
Inside Information / Other news releases
|
English | 341.3 KB | |
| 2025-04-25 17:45 |
Report Publication Announcement
Informations privilégiées / Autres communiqués
|
French | 285.5 KB | |
| 2025-04-25 17:45 |
Report Publication Announcement
Inside Information / Other news releases
|
English | 262.5 KB | |
| 2025-04-03 08:00 |
Regulatory News Service
Ikonisys SA : Hospitex International lance Urine24, la première plateforme de t…
|
French | 301.6 KB | |
| 2025-04-03 08:00 |
Regulatory News Service
Ikonisys SA: Hospitex International Launches Urine24, the First-Online Urinary …
|
English | 294.6 KB | |
| 2025-03-10 18:00 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 313.8 KB | |
| 2025-03-10 18:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 268.4 KB | |
| 2025-02-27 19:17 |
Inside Information Statement
Informations privilégiées / Autres communiqués
|
French | 342.1 KB | |
| 2025-02-27 19:17 |
Inside Information Statement
Inside Information / Other news releases
|
English | 342.9 KB | |
| 2025-01-15 07:30 |
Inside Information Statement
Inside Information / Other news releases
|
English | 330.9 KB | |
| 2025-01-15 07:30 |
Inside Information Statement
Informations privilégiées / Autres communiqués
|
French | 341.9 KB | |
| 2025-01-10 08:10 |
Inside Information Statement
Informations privilégiées / Autres communiqués
|
French | 281.0 KB | |
| 2025-01-10 08:10 |
Capital/Financing Update
Inside Information / Other news releases
|
English | 311.1 KB | |
| 2024-12-31 18:00 |
Inside Information Statement
Inside Information / Other news releases
|
English | 296.2 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |